Clinical Trial Update: CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors [NA]

View source ↗

Summary

Clinical trial update on producing and expanding CAR-NK cells from patients with lymphoproliferative or myeloproliferative disorders and from healthy donors, sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorders
• Myeloproliferative Neoplasms

Drugs mentioned

• CAR-NK cells (Chimeric antigen receptor natural killer cells)

Snippet

Sponsor: European Institute of Oncology | Conditions: Healthy Donors, Myeloproliferative Diseases | NA | Status: UNKNOWN